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Abstract
Four‐dimensional computerized tomography (4DCT) is required for stereotactic abla-
tive body radiotherapy (SABR) of mobile targets to account for tumor motion during
treatment planning and delivery. In this study, we report on the impact of an image
review quality assurance process performed prior to treatment planning by medical
physicists for 4DCT scans used for SABR treatment. Reviews were performed of
211 4DCT scans (193 patients) over a 3‐yr period (October 2014 to October 2017).
Treatment sites included lung (n = 168), kidney/adrenal/adrenal gland (n = 12), rib
(n = 4), mediastinum (n = 10), liver (n = 2), T‐spine (n = 1), and other abdominal sites
(n = 14). It was found that in 23% (n = 49) of cases patient management was
altered due to the review process. The most frequent intervention involved patient‐
speciﬁc contouring advice (n = 35 cases, 17%) including adjustment of internal tar-
get volume (ITV) margins. In 13 cases (6%) a rescan was requested due to extensive
motion artifact rendering the scan inadequate for SABR treatment planning. 4DCT
review by medical physicists was found to be an effective method to improve plan
quality for SABR.
K E Y WORD S
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1 | INTRODUCTION
Stereotactic ablative body radiotherapy (SABR) is characterized by
high radiation doses delivered in one or few treatment fractions.
SABR has been shown to be safe and effective for patients with
early‐stage non‐small cell lung cancer1–3 and kidney cancer,4,5 and
shown promise for liver,6,7 spine8 and oligometastatic disease,9,10 as
well as pancreas and prostate,11 in select patients. SABR treatment
requires image guidance for accurate delivery, particularly for mobile
targets. Patient immobilization and motion management strategies
are used to ensure treatment is delivered as planned. For mobile tar-
gets, retrospectively binned 4D‐computed tomography (4DCT) scans
may be performed to generate volumetric images at each phase of
the breathing cycle. From the tumor motion in the individual phases,
one can generate an internal target volume (ITV) which encompasses
the GTV as well as its motion. Due to the risk of artifacts in 4DCTs,
our institution has adopted a policy that these scans are reviewed
by a medical physicist prior to treatment planning to ensure that the
image is suitable for approximation of the tumor motion due to res-
piration as well as for the creation of a reasonable reference image
for image guidance. Ideally, the ITV contour must encompass the
size of the tumor as well as its full excursion throughout the entire
respiratory cycle.
Irregular breathing patterns or 4DCT reconstruction errors such
as one phase not reconstructing properly may lead to systematic
errors in ITV delineation propagating through the treatment chain
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which may not be obvious upon reviewing the maximum intensity
projection (MIP) or average scans alone. Recently the European
Organisation for Research and Treatment of Cancer (EORTC) multi-
centre Lungtech trial reported on the results of RTQA activities for
4DCT across 11 centers. Large deviations in contour volume of up
to 99% were found across different sites despite imaging the same
phantom under the same motion pattern.12 The effects of irregular
breathing patterns on ITV delineation of moving targets in the con-
text of lung SABR have been described by Clements et al.13 who
demonstrated erroneous ITV delineation using MIP images for mov-
ing targets with large amplitude undergoing irregular motion pat-
terns. Similar ﬁndings have been reported by Park et al.14 who
determined that the MIP underestimated the true target motion in
the case of irregular motion. Measured PTV dose discrepancies of
greater than 10% were reported by Huang et al.15 for irregular
motion patterns in a moving phantom for targets with large excur-
sions, demonstrating systematic under‐dose of the PTV periphery in
such cases. Clinical consequences may be severe, since systematic
PTV under‐dosing from inappropriate ITV delineation will result in
compromised tumor control probability. This risk is heightened in the
superior‐inferior direction for co‐planar ﬁeld deliveries where the
dose falloff is steepest. Therefore, it is essential that the appropriate-
ness of all 4DCT imaging be veriﬁed prior to clinical use to ensure
that images derived are a true representation of the full tumor
excursion, particularly in cases of irregular breathing.
This study presents the ﬁndings of independent, prospective
reviews performed by radiation oncology medical physicists of 211
patient 4DCT scans acquired for SABR pretreatment planning in a
large radiotherapy centre. We report on the frequency of required
intervention as a result of the review process and correlation with
regularity of patient breathing trace.
2 | MATERIALS AND METHODS
Review guidelines for 4DCT image sets were developed based on
commissioning work16 and experiences from quality assurance for
several clinical trials.17,18 An in‐house training programme was devel-
oped for medical physicists to establish a minimum skillset for per-
forming 4DCT reviews in the context of SABR. A patient‐speciﬁc
review checklist was designed to aid in the review process and facili-
tate data collection, which has been provided as supplementary
material.
4D‐computed tomography scans were acquired on a Brilliance
widebore 16‐slice scanner (Philips Medical Systems, Eindhoven, the
Netherlands) using retrospective gating with a gantry rotation period
of 0.44 s, 140 kVp and a pitch adjusted based on the breathing rate
with a resulting patient dose approximately twice the one of a 3D
scan.19 4DCT was also performed for lesions where dose calculation
was likely to be affected by surrounding mobile structures, such as
ribs and lower thoracic spine at the level of the diaphragm. Respira-
tion was monitored using the Philips bellows system afﬁxed to the
patients’ abdomen.20 Audio or visual coaching was not routinely
used however if irregular breathing was noted during the surview
scan, radiation therapists would pause the scan procedure to provide
basic coaching, although some patients still could not breath regu-
larly throughout the entire scan. The resulting respiratory trace was
used for phase binning, creating 10 phases of the breathing cycle.
Maximum intensity projection (MIP) and average datasets, which are
used for ITV delineation and dose calculation, respectively, were
reconstructed from the raw data. The MIP was used for ITV delin-
eation. 4DCT scans were reviewed by a medical physicist prior to
treatment planning. Review was performed on the CT console, using
the PulmoViewer application. This application allows visualization of
the breathing trace with the 4DCT image data, as well as tools to
determine the corresponding breath at each superior‐inferior scan
location. Tumor motion was measured using the ruler tool provided
in PulmoViewer to assess the maximum displacement of the lesion
between maximum inhale and exhale phases. The tumor boundaries
were identiﬁed using the radiation oncologists contour when avail-
able, or through diagnostic imaging in consultation with radiation
oncologists. A single, well‐deﬁned edge of the tumor on each phase
was used to determine motion, therefore this is an estimate of
tumor motion rather than the motion of the centre of mass. Choice
of tumor edge was at the discretion of the reviewing physicist and
was case‐speciﬁc, though usually the inferior‐most aspect of the
lesion was chosen if well‐deﬁned. If the 4DCT was deemed by the
medical physicist to not be an accurate representation of tumor
motion, advice was provided on whether to rescan the patient or
adjust planning target volume (PTV) margins to account for increased
uncertainty, along with an estimate of the uncertainty.
4D‐computed tomography review data were collected from three
radiotherapy facilities across our institution over a 3‐yr period
between October 2014 and October 2017. Outcomes of the 4DCT
reviews were assessed and each patient breathing trace were classi-
ﬁed according to regularity. Respiration cycles were classiﬁed as
either “regular”, “adequate”, or “irregular”. For a breathing trace to
be considered “regular”, the breathing pattern had to be consistent,
repetitive in its amplitude and frequency, and free of signiﬁcant
irregularities, such as a halt in breathing or considerable change in
breathing pattern. “Adequate” scans contained some irregularities,
such as a change in breathing pattern, but not affecting the tumor
level. “Irregular” scans contained considerable irregularity in breath-
ing pattern at some point during scanning level of tumor excursion,
or a change in breathing at the tumor level severe enough such that
the subsequent image would not fully capture the tumor motion.
Examples of “irregular” breathing traces at the tumor level are shown
in Fig. 1. Breathing classiﬁcation was made qualitatively, based on
the judgment of the reviewing medical physicist. Additionally, the
tumor size and motion was documented for each case, including
whether hysteresis was evident in the tumor excursion throughout
the respiratory cycle. Hysteresis was determined by observation of
tumor motion on all phases viewed on the sagittal plane. Tumor
motion in the anterior‐posterior direction as well as superior‐inferior
was classiﬁed as containing hysteresis. Reported CT dose index
(CTDI), pitch and breathing rates were also recorded. Breathing rates
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were measured using the tool provided in the PulmoView software,
which reports both the average and location‐speciﬁc breathing rate
as chosen by the user. The outcomes from each review regarding
patient management were also assessed.
3 | RESULTS
Between October 2014 and October 2017, a total of 597 patients
scanned with 4DCT were treated using SABR. Of those, 211 4DCT
scan records were available for this retrospective audit. Target loca-
tions included lung (n = 168), kidney/adrenal/adrenal gland (n = 12),
rib (n = 4), mediastinum (n = 10), liver (n = 2), T‐spine (n = 1) and
other abdominal sites (n = 14). Review of 4DCT scans required
approximately 20 min of medical physicists’ time per patient. As the
SABR programme increased capacity, the number of 4DCT reviews
was found to steadily increase.
The number of patient breathing traces which were considered
“regular”, “adequate” or “irregular” is shown in Fig. 2. The impact on
patient management for each category is also shown. No issues
were found for 162 patients (77%) and the scans were used for
SABR treatment planning without intervention. Of those 162
patients, 136 (84%) had regular breathing patterns, 19 (12%) had
adequate regularity and 7 (4%) were considered irregular. For
remaining cases (n = 49, 23%), 4DCT reviews revealed issues with
the ﬁnal images and required intervention. A re‐scan was subse-
quently requested in 13 cases (6%) due to excessive motion artifact
rendering the ﬁnal images unsuitable for ITV delineation for SABR
treatment planning. For remaining cases (n = 35, 17%), advice to use
modiﬁed margins in ITV delineation or other contouring advice
including fusion of staging images such as PET was provided to com-
pensate for deﬁciencies in the 4DCT scan based on advice from the
reviewing medical physicist.
Figure 3 shows the average breathing rate throughout the 4DCT
scan and recorded breathing rate at the tumor level, with data
grouped according to intervention type. The line of identity is shown
by a solid line with a ±10% margin indicated by the dashed lines. It
can be seen that breathing rate at the tumor level compared to
breathing rate throughout the scan did not necessarily predict inter-
vention requirements.
The amplitude of total tumor motion is shown in Fig. 4 as a
function of breathing rate at the tumor level, with data grouped
according to intervention requirements. Tumors with motion less
than 3 mm did not require intervention regardless of breathing rate.
Large tumor excursion or rapid breathing rate were not predictors
for intervention.
Table 1 shows the frequency of tumor hysteresis throughout the
respiratory cycle. Hysteresis was observed in 30% of patients in this
study and is often noted for inferiorly located lesions close to the
posterior chest wall.
Comments in the review form were reviewed to determine the
cause of the artifacts. A number of common causes were identiﬁed:
1. The patient’s breathing was highly irregular, leading to poor
tumor deﬁnition in any one phase, and insufﬁcient quality to
determine range of tumor motion.
(a) (b) 
F I G . 1 . Examples showing irregular
breathing in the case of (a) breathing
stopped during scanning at the tumor
level, and (b) irregular breath at the tumor
level despite otherwise regular breathing.
The cross‐hairs indicate that the tumor and
the arrows mark the breathing track at the
tumor level
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F I G . 2 . Distribution of patient breathing traces according to
respiratory cycle regularity for 211 SABR patients. Change in patient
management as a result of 4DCT review is indicated by the shaded
bars. A total of 49 cases (23%) required change in patient
management. Of those, 25 (51%) were classiﬁed as ‘adequate’ or
‘irregular’ breathing
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2. The patient was breathing regularly, but coughed during the
acquisition
3. Patient was breathing regularly, but while the tumor was moving
through the scanning plane the patient stopped breathing, lead-
ing to the tumor appearing artiﬁcially stationary, with anatomy
superior and inferior moving with respiration.
4. Patient’s breathing continuously slowed down from initial scan
pitch setting to acquisition. This may have been due to medica-
tion to relax the patient for the scan
5. The patient did not exhale (or inhale) fully, while scanning
through the superior (or inferior) aspect of the tumor. This
resulted in the superior (or inferior) aspect of the tumor at full
expiration (inspiration) not being recorded, i.e., lack of informa-
tion on either end of the tumor excursion.
6. The patient had an unintended deep inspiration while the tumor
was moving through the scanning plane, leading to overestima-
tion of tumor motion
Reasons for physics consultations other than due to breathing
irregularity and motion estimation included overestimation of the
required tube current by the scanner software, slow breathing pat-
terns (<10 bpm not allowing 4DCT acquisition), inaccurate detection
of inhale peaks by the scanner software and poor image quality.
4 | DISCUSSION
This study reports on the outcomes of independent review for
patient 4DCT scans acquired for treatment of SABR to mobile tar-
gets. The aim of these reviews was to determine if each scan was a
reasonable representation of tumor motion throughout the breathing
cycle and was appropriate for the purposes of SABR treatment plan-
ning, including target (ITV) delineation and dose calculation.
One limitation of this study is the subjectiveness amongst differ-
ent physicists in performing quantitative analysis of patient 4DCT
reviews. While training was provided to harmonize interpretation,
there is still a degree of subjectiveness in the review process. Never-
theless, intervention was required in 23% of all reviewed cases.
Irregular breathing rate was found to be a contributor to inadequate
scans (16% of regular breathing traces requiring intervention com-
pared to 57% of scans classiﬁed as “irregular”, Fig. 2). One common
problem was identiﬁed as inappropriate choice of scan pitch. Scan-
ner pitch is adjusted based on patient breathing rate prior to com-
mencing a scan. A lower pitch is required to maximize the chance of
fully capturing tumor motion in the case of slower breathing rates.
The pitch is selected after the patient has spent some time in quiet
breathing and is monitored up until commencing a scan. However,
upon commencing a scan it was found in some cases that a patient
breathing rate can change, even throughout the duration of the scan.
In some cases the breathing stopped completely while scanning
through the level of the lesion, resulting in no visible tumor motion.
In such cases a rescan is required which usually addressed concerns
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F I G . 3 . Correlation between average breathing rate throughout
the 4DCT scan duration and breathing rate at the tumor level. The
solid line represents the line of identity and the dashed lines
represent ± 10% variation
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F I G . 4 . Change in patient management is shown relative to tumor
amplitude and patient breathing rate (breaths per minute, BPM) at
the tumor level. Motion less than 3 mm required no intervention.
Breathing rate was not a predictor for intervention requirements
TAB L E 1 Summary cases involving tumor hysteresis. Hysteresis
was observed in 64 out of 211 4DCT scans (30%). For the 48 cases
requiring some change in patient management, 23 cases (48%) were
observed to have tumor hysteresis compared with 41 out of 163
(25%) of cases where no intervention was required
Hysteresis
No issues
Re‐scan or
advice
n % n %
Yes/Slight 41 25 23 48
No 122 75 25 52
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raised in the ﬁrst scan, unless a similar interruption in breathing pat-
tern occurred. In some cases irregular breathing was noted during
the scan but no intervention was required. This may be due to the
irregularity occurring at anatomical locations away from the target
region. In such cases, irregular breathing is noted but if the target
region is unaffected intervention is not warranted. Since changes in
breathing rate were shown to be a signiﬁcant contributor to motion
artifacts in our centre, radiation therapists have subsequently begun
monitoring the respiratory trace closely during a scan. If irregular
breathing is indicated during a scan, a physicist is called to review
the respiratory trace while the patient is still on‐site. This facilitates
more timely re‐scans where warranted without the need to call a
patient back to hospital.
Figure 1 shows that both large [Fig. 1(a)] and quite subtle
[Fig. 1(b)] irregularities can impact on motion assessment. Both
breathing frequency and amplitude can have a detrimental impact.
Through the examples shown in this study, amplitude can have a
major impact if the tumor isn’t moving its “normal” extent during
acquisition then tumor motion will not be sufﬁciently captured.
However, irregularities in frequency also impact our assessment due
to discontinuity artifacts, which is often inter‐related to image acqui-
sition parameters such as pitch factor and gantry speed. It is thus
quite challenging to quantify respiratory trace irregularities in a man-
ner that can be applied routinely in the clinic. Thus, ongoing patient‐
speciﬁc reviews are required.
Typically a 4DCT scan acquires images of each anatomical slice
for the duration of one to two breaths. Just one irregular breath can
therefore distort the resulting image at a given anatomical slice.
Review of PET scans (if available) acquired over several minutes was
used to augment the relevant information where necessary. Also the
CBCT, or 4D‐CBCT if available, on the ﬁrst treatment day can be
used to validate the motion estimates. 4D cone‐beam CTs were
occasionally acquired to evaluate motion, as these are more robust
to breathing irregularity due to the whole anatomy being imaged for
at least 2 min worth of breathing. It should be noted that due to the
fact that 4DCTs are only acquiring motion from 1 to 2 breaths, cou-
pled with the sampling frequency, the treatment respiratory motion
is underestimated in 4DCTs.21 This means that any underestimation
of the motion from 4DCTs is potentially more signiﬁcant relative to
treatment motion.
Tumor hysteresis was noted in 30% of cases (n = 64). Of those,
48% required intervention compared to 25% of cases without hys-
teresis. Although this study is not powered to compare intervention
rates with and without tumor hysteresis the differences are worth
noting. It may be that a more complex motion pattern has a higher
chance of being missed in the presence of artifacts, compared to a
more simple superior/inferior motion pattern.
Earlier studies suggest that artifacts in 4DCT are common and
associated with breathing irregularity.22 Patient training, coaching
and feedback would be helpful to improve patient compliance with
regular and reproducible breathing.23 Furthermore, thoracic lesions
are subject to often complex motion patterns depending on the loca-
tion and can even be affected by cardiac motion.24 Individualized
ITVs based on respiratory‐gated 4DCT are therefore necessary for
improving target deﬁnition.25 The additional anterior‐posterior and
left‐right motion requires careful consideration of each phase of the
breathing cycle, since the maximum inhale and maximum exhale may
not capture the intermediate motion patterns. Use of the maximum
intensity projection (MIP) image or all individual phases for ITV delin-
eation ensures tumors with hysteresis are fully captured.
5 | CONCLUSIONS
Patient‐speciﬁc 4DCT reviews by a medical physicist was shown to
have a signiﬁcant impact on patient management in a large cohort of
patients treated with SABR to moving lesions with a high interven-
tion rate of 23% of all cases. Irregular breathing patterns during
4DCT scans were shown to cause artefacts which may impact on
the resulting ITV contours, hence treatment ﬁelds. In 23% of cases
the physicist was able to advise on margins to accommodate for lost
motion during the scan, while in other cases a rescan was required.
Tumor hysteresis was noted in 30% of scans, requiring careful
review of all phases to ensure tumor excursion is fully captured in all
directions of motion. Results from this study suggest patient‐speciﬁc
4DCT QA should be a mandatory part of a patient’s treatment path-
way in SABR treatments of moving targets to ensure motion is ade-
quately captured for the purposes of motion management and
treatment planning.
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